麝香保心丸联合厄贝沙坦治疗急性心肌梗死患者的有效性和安全性

Efficacy and Safety of Shexiang Baoxin Pill Combined with Irbesartan in Treatment of Patients with Acute Myocardial Infarction

目的研究厄贝沙坦联合麝香保心丸治疗急性心肌梗死患者的有效性和安全性。方法选取62名急性心肌梗死患者,分为对照组(30例)和实验组(32例),对照组采用常规西药治疗,实验组在对照组基础上联合使用厄贝沙坦及麝香保心丸。治疗一个疗程后,比较两组患者治疗效果及心功能等临床指标。结果实验组总治疗有效率明显高于对照组,差异有统计学意义(P<0.05);治疗后实验组心功能指标均优于对照组,且两组患者治疗后各指标均优于治疗前,且差异均有统计学意义(P<0.05)。结论厄贝沙坦联合麝香保心丸能够明显提高急性心肌梗死的治疗效果。

Objective To investigate the efficacy and safety of Shexiang Baoxin Pill in patients with acute myocardial infarction. Methods Totally 62 acute myocardial infarction patients were selected as the main study subjects and divided into the control group(30 patients)treated with conventional Western medicine and experimental group(32 patients)given treatment on the basis of the control group with combination of Shexiang Baoxin Pill. After one course of treatment,the clinical indicators such as therapeutic effect and cardiac function were compared between the two groups. Results The total effective rate of the experimental group was significantly higher than the control group(P<0.05);after treatment,the experimental group heart function indicators were better than the control group,and the two groups of patients after treatment were better than the indicators before treatment(P<0.05). Conclusion The combined use of Shexiang Baoxin Pill can significantly improve the therapeutic effect of acute myocardial infarction.